MIRM 8-K 2026-10-13

Mirum Pharmaceuticals, Inc. (MIRM) 8-K dated 2026-10-13 — accession 0001759425-26-000051. This URL is the filing, not the MIRM hub.

Mirum Pharmaceuticals, Inc. (MIRM) is a biotechnology company listed on NASDAQ.

Mirum Pharmaceuticals, Inc. filed a 8-K on 2026-10-13. Accession 0001759425-26-000051.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MIRM revenue for 2025-12-31 was $521.3M. Net income was -$23.4M. Revenue was up 54.7% from 2024-12-31 to 2025-12-31. MIRM currently screens at market cap $6.22B.

Not investment advice. The MIRM SEC hub lists recent forms. The stock page is the research view.